Diabetes
Showing NaN - NaN of 87
Developing Enhanced Prediction Models
Completed
- Acute Myocardial Infraction or Chest Pain
- +4 more
-
Philadelphia, PennsylvaniaPenn Medicine
Feb 5, 2020
Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of
Completed
- Acute Ischemic Stroke
- +2 more
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
-
Tucson, Arizona
- +69 more
Dec 13, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +208 more
Oct 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Little Rock, Arkansas
- +80 more
Jun 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Tucson, Arizona
- +151 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Phoenix, Arizona
- +98 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- +2 more
-
Phoenix, Arizona
- +72 more
Jun 3, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Phoenix, Arizona
- +154 more
May 22, 2019
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +165 more
Apr 30, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Concord, California
- +96 more
Mar 6, 2019
Diabetes, Cardiovascular Disease Trial in Philadelphia (Process Incentive, Outcome Incentive)
Completed
- Diabetes
- Cardiovascular Disease
- Process Incentive
- Outcome Incentive
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 25, 2019
HIV, Cardiovascular Disease, Diabetes Trial in Philadelphia (Health Promotion Intervention, Health Awareness Control
Completed
- HIV
- +4 more
- Health Promotion Intervention
- Health Awareness Control Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Feb 4, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin glargine
-
Fresno, California
- +90 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- insulin degludec
-
Huntsville, Alabama
- +85 more
Dec 7, 2018
Diabetes, Diabetes, Type 1 Trial in Poland, Puerto Rico, United States (insulin degludec, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Birmingham, Alabama
- +98 more
Dec 7, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin detemir, Insulin NPH, Diet/exercise)
Terminated
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin detemir
- +2 more
-
Tucson, Arizona
- +81 more
Aug 9, 2018
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (insulin aspart, inhaled human insulin)
Terminated
- Diabetes
- +3 more
- insulin aspart
- inhaled human insulin
-
Fresno, California
- +31 more
Sep 3, 2018
Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)
Terminated
- Diabetes
- Diabetes Mellitus, Type 1
- inhaled human insulin
- +2 more
-
Birmingham, Alabama
- +95 more
Sep 3, 2018
Diabetes, Cardiovascular Disease Trial in Philadelphia (Twitter Diabetes Intervention)
Completed
- Diabetes
- Cardiovascular Disease
- Twitter Diabetes Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 31, 2018
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/liraglutide
- +2 more
-
Tuscumbia, Alabama
- +116 more
Mar 1, 2018